Cheat Sheet: How to challenge patents under the America Invents Act
On Sept. 16, new methods of challenging patents before the Patent and Trademark Office (PTO) went into effect, thanks to the America Invents Act.
December 11, 2012 at 04:15 AM
12 minute read
The original version of this story was published on Law.com
On Sept. 16, new methods of challenging patents before the Patent and Trademark Office (PTO) went into effect, thanks to the America Invents Act. Three of the four methods available to businesses now are brand-new, and similar to litigation. The last, ex parte re-examination, has been around for a while, but is pricier in this incarnation.
Our December issue guides in-house counsel through each of these methods and advises companies to carefully consider their options before challenging a patent. Each of the methods has “distinct advantages and disadvantages,” according to Reed Smith Partner Marc Kaufman. In this cheat sheet, we'll sum up what you need to know about each of the options to bring a challenge before the PTO.
Ex parte re-examination
Though the cost for this method has increased from $2,520 per challenged patent to $17,750 per challenged patent, it remains the cheapest option. At any point after a patent issues, you can provide the PTO with evidence that it was anticipated by printed publications or another patent. A patent examiner will investigate and come to a conclusion, with no effort required on the part of the challenger.
However, leaving your challenge in the hands of an examiner means that you won't be able to advocate for your position. If the examiner upholds the patent, you can try again using one of the other three methods.
Inter partes review
Like ex parte re-examination, inter partes review is for challenges that claim a patent was anticipated by another patent or by a printed publication. Unlike ex parte re-examination, this method can't be used during the first nine months after a patent is issued and requires the challenger's active participation.
Inter partes review is a lot like litigation in that there are declarations by experts, depositions, orders and a trial in front of PTO administrative law judges. Discovery is more limited and proceedings are more streamlined in inter partes review than in litigation, so while it doesn't come cheap, it is still cheaper than going to court. And faster—the PTO claims that nearly all inter partes reviews will be decided within 12 months.
Post-grant review
Post-grant review is a lot like inter partes review, in that it is structured similarly to litigation. But while inter partes review only allows for anticipatory challenges, post-grant review enables you to challenge a patent on any grounds of invalidity. You can seek post-grant review only during the first nine months after a patent has issued, starting with patents filed on or after March 16, 2013.
The downside to post-grant review is that it comes with a broad estoppel on any claim of invalidity that you raise, which would prevent you from challenging the same patent in other proceedings. If post-grant review seems like the best option for your company, you need to make sure you have all of your strongest arguments at the ready, because you may not get another chance to challenge that patent.
The transitional program for covered business method patents
Aside from being a mouthful to say, the transitional program for covered business method patents is a way to specifically attack patents on financial products or services. It is similar to post-grant review in that you're able to challenge the patent on any grounds of invalidity, but it is only available as an option if you have been sued for infringing the challenged patent, or have a reasonable fear that you will be sued.
There is also some question as to what exactly constitutes a financial product or service. According to Reed Smith Partner Marc Kaufman, “the definition is unclear.”
For patents that issue before March 16, 2013, business can use this program to challenge them right away. After that date, you'll have to wait nine months before challenging the patent.
On Sept. 16, new methods of challenging patents before the Patent and Trademark Office (PTO) went into effect, thanks to the America Invents Act. Three of the four methods available to businesses now are brand-new, and similar to litigation. The last, ex parte re-examination, has been around for a while, but is pricier in this incarnation.
Our December issue guides in-house counsel through each of these methods and advises companies to carefully consider their options before challenging a patent. Each of the methods has “distinct advantages and disadvantages,” according to
Ex parte re-examination
Though the cost for this method has increased from $2,520 per challenged patent to $17,750 per challenged patent, it remains the cheapest option. At any point after a patent issues, you can provide the PTO with evidence that it was anticipated by printed publications or another patent. A patent examiner will investigate and come to a conclusion, with no effort required on the part of the challenger.
However, leaving your challenge in the hands of an examiner means that you won't be able to advocate for your position. If the examiner upholds the patent, you can try again using one of the other three methods.
Inter partes review
Like ex parte re-examination, inter partes review is for challenges that claim a patent was anticipated by another patent or by a printed publication. Unlike ex parte re-examination, this method can't be used during the first nine months after a patent is issued and requires the challenger's active participation.
Inter partes review is a lot like litigation in that there are declarations by experts, depositions, orders and a trial in front of PTO administrative law judges. Discovery is more limited and proceedings are more streamlined in inter partes review than in litigation, so while it doesn't come cheap, it is still cheaper than going to court. And faster—the PTO claims that nearly all inter partes reviews will be decided within 12 months.
Post-grant review
Post-grant review is a lot like inter partes review, in that it is structured similarly to litigation. But while inter partes review only allows for anticipatory challenges, post-grant review enables you to challenge a patent on any grounds of invalidity. You can seek post-grant review only during the first nine months after a patent has issued, starting with patents filed on or after March 16, 2013.
The downside to post-grant review is that it comes with a broad estoppel on any claim of invalidity that you raise, which would prevent you from challenging the same patent in other proceedings. If post-grant review seems like the best option for your company, you need to make sure you have all of your strongest arguments at the ready, because you may not get another chance to challenge that patent.
The transitional program for covered business method patents
Aside from being a mouthful to say, the transitional program for covered business method patents is a way to specifically attack patents on financial products or services. It is similar to post-grant review in that you're able to challenge the patent on any grounds of invalidity, but it is only available as an option if you have been sued for infringing the challenged patent, or have a reasonable fear that you will be sued.
There is also some question as to what exactly constitutes a financial product or service. According to
For patents that issue before March 16, 2013, business can use this program to challenge them right away. After that date, you'll have to wait nine months before challenging the patent.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllAdvertising Tech Likely to Draw More Scrutiny in 2025 Over Consumers' Data, Lawyers Say
5 minute read'Be Comfortable Being Uncomfortable': Pearls of Wisdom From 2024 GC Q&As
In-House Moves of the Month: Boeing Loses Another Lawyer, HubSpot Legal Chief Out After 2 Years
5 minute readTrending Stories
- 1Deal Watch: Latham, Paul Weiss, Debevoise Land on Year-End Big Deals. Plus, Mixed Messages for 2025 M&A
- 2Bathroom Recording Leads to Lawyer's Disbarment: Disciplinary Roundup
- 3Conn. Supreme Court: Workers' Comp Insurance Cancellations Must Be Unambiguous
- 4To Avoid Conflict, NYAG Hands Probe Into Inmate's Beating Death to Syracuse-Area DA
- 5Scripture-Quoting Employee Sues Company for Supporting LGBTQ Pride
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250